The Immune System’s Redesigned Role in Fighting Cancerous Tumors

A Novel Combination of Two Agents Eradicates Solid Tumors in Preclinical Studies March 11, 2014 Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine. The study’s findings, published in …